Special Announcement - Now Enrolling for FDA Approved Stem Cell Study
Dr. Mitchell Sheinkop has completed training and is credentialed for the first of its kind FDA approved stem cell clinical trial for knee arthritis. Our clinic is now enrolling patients in this trial. Contact us at 312-475-1893 for details. Click here to learn more.

Last week, I disclosed that I myself had undergone an Autologous Protein Concentrate intervention into both of my knees on December 27 and the results to date are remarkable. For those who missed the last Blog, I confessed that I have been experiencing progressive pain and some limitation of function from Osteoarthritic changes in my knees. Now I am admitting that on January 11, owing in part to the initial success in my knees coupled with my increasing frustration in putting on my shoes and socks because of progressive loss of motion at the hip, I underwent an Autologous Protein Concentrate intervention into both of my hips.

Long ago, I was told during my orthopedic residency training that in order to retain, information must be repeated three times or painfully once. Autologous Protein Concentrate (APC) may be the end result of a Bone Marrow Aspiration or derived from your circulating blood. I am initially using APC for patients over age 70 or for those who have extensive arthritic changes in a joint or who are immune-suppressed or otherwise pharmacologically dependent on drugs that potentially limit the success of a Stem cell intervention. The Autologous Protein Concentrate has precursor cells, Interleukin 1 Receptor Antagonists and Tumor Necrosis Factor alpha antagonists. The two-year clinical results in Western Europe, suggest that should the FDA in the next two and a half years as they posted on September 16, 2017, put constraints on the practice of Regenerative Medicine to finally weed out the charlatans; those of us practicing Cellular Orthopedics will prevail and be rewarded for integrity.

Let me share with you my activity profile last weekend which I believe is the best possible initial measure of the Autologous Protein Concentrate outcome. Please be reminded that in our outcomes data base includes an activity outcome score and it is the latter that I believe best measures the success of a cellular orthopedic procedure. On Saturday, I continually climbed over ladders placed by the Wisconsin DNR allowing me access to Spring Coulee in the Driftless region of Southwest Wisconsin.  My purpose was to initiate the 2018 fly fishing season taking advantage of the 42-degree temperature with a blue sky. I covered over five miles along and at times in an ever-winding spring creek. Along the way, I vaulted ice on the stream edges; at others, I had to tromp through snow drifts and semi vault over barbed wire cattle fences. The day started at 10am and finished at dark, 5:30pm. On Sunday, the exercise was repeated, this time on Tainter Creek. On Monday, I headed home, had dinner with my wife and headed to the fitness club to stretch and strengthen.

None of this would have been possible prior to December 27, 2017, when I initiated the care and treatment of my arthritic knees and then hips with Autologous Protein Concentrate. My next venture will be a week of Colorado skiing in mid-February with wife, children and grandchildren.  I share the autobiography of my knees and hips so you will understand I feel your pain. That’s All Folks as I am off to the health club. To repeat the message, you may call for an appointment:  847-390-7666 or study the web site and then watch the Webinar:    www.ILcellulartherapy.com

Pin It on Pinterest

Share This